susceptibility pattern of candida albicans isolated from iranian patients to antifungal agents
Clicks: 198
ID: 192080
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
198 views
29 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #28 of 37 articles by views in Ciencia & saude coletiva
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background and Purpose: Candidiasis is a major fungal infection, and Candida albicans is the major cause of infections
in humans. The Clinical and Laboratory Standards Institute (CLSI) developed new breakpoints for antifungal agents
against C. albicans. In this multi-center study, we aimed to determine the drug susceptibility profile of C. albicans,
isolated from Iranian population according to new species-specific CLSI.
Materials and Methods: Clinical samples were cultured on Sabouraud dextrose agar and were incubated at room temperature for seven days. The isolates were transferred to Professor Alborzi Clinical Microbiology Research Center, Shiraz,
Iran. C. albicans were identified by using API 20C AUX system. Broth microdilution method was used to determine
the minimum inhibitory concentrations (MICs) of amphotericin B, caspofungin, voriconazole, fluconazole, posaconazole,
itraconazole, and ketoconazole, based on CLSI document M27-S4 and new breakpoints for some azoles and caspofungin.
Results: Overall, 397 C. albicans were isolated from patients admitted to ten university hospitals in Iran. The MIC90
of the isolates to amphotericin B, caspofungin, voriconazole, fluconazole, posaconazole, itraconazole, and ketoconazole
were 0.125, 0.125, 0.125, 1, 0.064, 0.5, and 0.125 μg/ml, and rates of resistance were 0.5%, 0.3%, 3.8%, 2.8%, and 2.5%
for amphotericin B, caspofungin, voriconazole, fluconazole, and itraconazole, respectively.
Conclusion: According to our data, fluconazole is the drug of choice for management of patients at risk for systemic
candidiasis throughout the region, since it is cost-effective with low side effects.
| Reference Key |
badiee2016currentsusceptibility
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Parisa Badiee;Hamid Badali;Kambiz Diba;Abdolkarim Ghadimi Moghadam;Ali Hosseininasab;Hadis Jafarian;Rasoul Mohammadi;Hossein Mirhendi;Mohammad Javad Najafzadeh;Ahmad Shamsizadeh;Jafar Soltani |
| Journal | Ciencia & saude coletiva |
| Year | 2016 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.